前往化源商城

烟酸占替诺

更新时间:2025-08-27 19:36:01

烟酸占替诺结构式
烟酸占替诺结构式
品牌特惠专场
常用名 烟酸占替诺 英文名 Xanthinol Nicotinate
CAS号 437-74-1 分子量 434.446
密度 N/A 沸点 589.3ºC at 760 mmHg
分子式 C19H26N6O6 熔点 180-184ºC
MSDS N/A 闪点 310.2ºC

 烟酸占替诺用途


Xanthinol Nicotinate (Xanthinol Niacinate) 是一种血管扩张剂,可以直接作用于小动脉和毛细血管的平滑肌。Xanthinol Nicotinate 可以扩大血管,改善血液流变学并降低外周血管阻力。

 烟酸占替诺名称

中文名 烟酸占替诺
英文名 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione,pyridine-3-carboxylic acid
中文别名 7-[2-羟基-3-(2-羟乙基-甲胺基)丙基]苯碱烟酸盐 | 尼可占替诺 | 脑康 | 7-[2-羟基-3-(2-羟乙基-甲胺基)丙基]-1,3-二甲基-嘌呤-2,6-二酮烟酸盐 | 7-[3-[(2-羟乙基)甲氨基]-2-羟丙基]茶碱尼古丁酸酯
英文别名 更多

 烟酸占替诺生物活性

描述 Xanthinol Nicotinate (Xanthinol Niacinate) 是一种血管扩张剂,可以直接作用于小动脉和毛细血管的平滑肌。Xanthinol Nicotinate 可以扩大血管,改善血液流变学并降低外周血管阻力。
相关类别
体外研究 烟酸黄原醇(烟酸黄原醇;2.76-276μM;24小时)以剂量依赖性方式抑制HUASMC增殖[2]。烟酸黄原醇(2.76-276μM;24小时)剂量依赖性地降低HUASMCs细胞膜上PDGFR-mRNA和PDGFR-β的水平[2]。细胞增殖试验[2]细胞系:人脐动脉平滑肌细胞(HUASMC)浓度:2.76、27.6或276μM培养时间:24小时结果:抑制HUASMC增殖呈剂量依赖性。Western Blot分析[2]细胞株:huascm浓度:2.76、27.6或276μM孵育时间:24小时结果:剂量依赖性降低huascm细胞膜上PDGFR mRNA和PDGFR-β水平。
体内研究 烟酸黄原醇(烟酸黄原醇;75mg/kg;IP)能快速、短暂地改变肿瘤pO2,最大pO2值在烟酸黄原醇给药后10~30min内获得[1]。烟酸黄原醇能够在肿瘤复氧期间应用10gy的X射线对肿瘤进行放射增敏(放射反应增强1.4)[1]。动物模型:5周龄雄性NMRI小鼠[1]剂量:75mg/kg给药:IP结果:XN给药后10~30min,肿瘤pO2迅速、短暂改变,pO2值最大。
参考文献

[1]. Segers J, et al. Use of Xanthinol Nicotinate as a co-treatment for radio- and chemo-therapy in experimental tumors. Int J Cancer. 2010 Jan 15;126(2):583-8.

[2]. Bai X, et al. Inhibited proliferation of human umbilical artery smooth muscle cells by xanthinol nicotinate. Med Biol Eng Comput. 2016 Jun;54(6):891-8.

 烟酸占替诺物理化学性质

沸点 589.3ºC at 760 mmHg
熔点 180-184ºC
分子式 C19H26N6O6
分子量 434.446
闪点 310.2ºC
精确质量 434.191376
PSA 155.71000
InChIKey GEPMAHVDJHFBJI-UHFFFAOYSA-N
SMILES CN(CCO)CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C.O=C(O)c1cccnc1
外观性状 白色结晶粉末
蒸汽压 9.89E-15mmHg at 25°C
储存条件 -20℃

 烟酸占替诺MSDS

 烟酸占替诺毒性和生态

 烟酸占替诺安全信息

WGK德国 2
RTECS号 QT1500000
海关编码 2933990090

 烟酸占替诺海关

海关编码 2933990090
中文概述 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 烟酸占替诺靶点实验

查看更多实验

实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
实验名称:Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020);...
来源:ChEMBL
靶标:Staphylococcus aureus
External Id:CHEMBL4296184
实验名称:Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); ...
来源:ChEMBL
靶标:Klebsiella pneumoniae
External Id:CHEMBL4296186
实验名称:Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CA...
来源:ChEMBL
靶标:Escherichia coli
External Id:CHEMBL4296185
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify pos...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
实验名称:MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint...
来源:Broad Institute
靶标:N/A
External Id:2084-01_Activator_SinglePoint_HTS_Activity
实验名称:Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberc...
来源:The Scripps Research Institute Molecular Screening Center
靶标:N/A
External Id:GDH-TPI_INH_ABS_1536_1X%INH CSRUN
实验名称:qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
来源:NCGC
External Id:HERG01
实验名称:qHTS for Inhibitors of TGF-b: Cytotox Counterscreen
来源:NCGC
靶标:N/A
External Id:SMAD3201
共198条,当前第1页,共20页
1
2
3
4
5

 烟酸占替诺英文别名

Nicotinic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1)
7-[3-[N-(2-Hydroxyethyl)amino]-2-hydroxypropyl]theophylline nicotinate
Teonicol
Xanthinol Niacinate
Xantinol nicotinate
SK 331-A
Angioamin
Xantinol Niacinate
Complamex
EINECS 207-115-7
Xanthinolnicotinat
Sadamine
3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1)
Landrina
3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1)
Xanthinol nicotinate
Contamex
MFCD00058342
Xavin
Stenalgil
3-Pyridinecarboxylic acid compd with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1)
7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline compd with nicotinic acid
Complamin
pyridine-3-carboxylic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1)
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。